期刊
NATURE PROTOCOLS
卷 4, 期 9, 页码 1313-1327出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nprot.2009.117
关键词
-
资金
- Medical Research Council (UK)
- Wellcome Trust
- Merck Serono
- Charitable Trustees of St. George's Hospital, London
- MRC [G0601072, G0500628] Funding Source: UKRI
- Medical Research Council [G0500628] Funding Source: researchfish
Cell proliferation may be measured in vivo by quantifying DNA synthesis with isotopically labeled deoxyribonucleotide precursors. Deuterium-labeled glucose is one such precursor which, because it achieves high levels of enrichment for a short period, is well suited to the study of rapidly dividing cells, in contrast to the longer term labeling achieved with heavy water ((H2O)-H-2). As deuterium is non-radioactive and glucose can be readily administered, this approach is suitable for clinical studies. It has been widely applied to investigate human lymphocyte proliferation, but solid tissue samples may also be analyzed. Rate, duration and route (intravenous or oral) of [6,6-H-2(2)]-glucose administration should be adapted to the target cell of interest. For lymphocytes, cell separation is best achieved by fluorescence activated cell sorting (FACS), although magnetic bead separation is an alternative. DNA is then extracted, hydrolyzed enzymatically and analyzed by gas chromatography mass spectrometry (GC/MS). Appropriate mathematical modeling is critical to interpretation. Typical time requirements are as follows: labeling, 10-24 h; sampling, similar to 3 weeks; DNA extraction/derivatization, 2-3 d; and GC/MS analysis, similar to 2 d.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据